Zelta
Zelta (formerly IBM® Clinical Development) is a unified, cloud-based Clinical Data Management System designed to help reduce the cycle time to start, amend, and manage clinical studies — enabling life sciences organizations to deliver therapies and innovations faster to their patients. Boasting a proven track record of over 4000+ clinical trials, in 109 countries, with 1 million+ participants, the vendor states Zelta will help pharmaceutical, medical device, and CROs to shorten study cycle time and reduce costs. In addition to its core electronic data capture (EDC) functionality, Zelta offers a fully-integrated portfolio of modules that are designed to suit every trial, including: Medical Coding with AI- Designed to increase efficiency by leveraging AI to build consistency and reduce errors eConsent - Delivers easy remote participant consenting without additional EDC integration Open Platform Data Integration - Allows users to build and automate data connectors with minimal coding Reporting and Analytics - Provides Data Managers to use pre-built or custom reports to derive single and cross-study insights Electronic Clinical Outcome Assessment (eCOA) - Strengthens Participant Centricity with live, automatic data sync with EDC
Average Rating: 4.7/5.0
Total Reviews: 3
How Do G2 Users Rate Zelta?
- Data Capture - Electronic Data Capture (EDC): 10.0/10 (Category avg: 9.0/10)
- Compliance - Electronic Data Capture (EDC): 8.3/10 (Category avg: 8.8/10)
- eCRFs - Electronic Data Capture (EDC): 10.0/10 (Category avg: 8.8/10)
- Quality of Support: 9.4/10 (Category avg: 8.8/10)
Who Is the Company Behind Zelta?
- Seller: Merative
- Year Founded: 2022
- HQ Location: Ann Arbor, US
-
LinkedIn® Page: www.linkedin.com
1,594 employees on LinkedIn®
Who Uses This Product?
- Company Size: 33% Large, 33% Medium
What Are Recent G2 Reviews of Zelta?
"Zelta Makes Designing and Running Clinical Trials a Breeze"
Rating: 5.0/5.0 stars
— Verified User in Pharmaceuticals
Rating: 4.5/5.0 stars
— Ashiqa M.

